Steep declines in SARS-CoV-2 test revenue were reported by the top in vitro diagnostics (IVD) companies in Q2 2023 earnings compared to a year earlier. For some of those firms, the coronavirus testing drops equate to billions of dollars in lost revenue. In response to the decreasing demand for COVID-19 testing, IVD manufacturers are scrambling …
IVD Companies Launch New Assays, Analyzers, Automation Read More »
